000			02170nam a2200445 i 4500
001			ebr11003355
003			CaPaEBR
007			cr cn|||||||||
008			150121t20142014dcua ob 000 0 eng d
020			_z9780309310000
020			_a9780309310017 (e-book)
040			_aCaPaEBR _beng _erda _epn _cCaPaEBR
035			_a(OCoLC)896380256
050	1	4	_aT174.5 _b.C378 2014eb
082	0	4	_a363.1 _223
100	1		_aCaruso, Denise, _eauthor.
245	1	0	_aCharacterizing and communicating uncertainty in the assessment of benefits and risks of pharmaceutical products : _bworkshop summary / _cDenise Caruso, Rebecca A. English, Anne B. Claiborne.
264		1	_aWashington, District of Columbia : _bThe National Academies Press, _c2014.
264		4	_c�2014
300			_a1 online resource (150 pages) : _billustrations, tables
336			_atext _2rdacontent
337			_acomputer _2rdamedia
338			_aonline resource _2rdacarrier
504			_aIncludes bibliographical references.
588			_aDescription based on online resource; title from PDF cover (ebrary, viewed January 21, 2015).
590			_aElectronic reproduction. Palo Alto, Calif. : ebrary, 2015. Available via World Wide Web. Access may be limited to ebrary affiliated libraries.
650		0	_aRisk assessment _vCongresses.
650		0	_aCommunication _vCongresses.
655		0	_aElectronic books.
700	1		_aEnglish, Rebecca A., _eauthor.
700	1		_aClaiborne, Anne B., _eauthor.
710	2		_aBoard on Health Sciences Policy.
710	2		_aInstitute of Medicine (U.S.). _bForum on Drug Discovery, Development, and Translation.
710	2		_aInstitute of Medicine (U.S.)
776	0	8	_iPrint version: _aCaruso, Denise. _tCharacterizing and communicating uncertainty in the assessment of benefits and risks of pharmaceutical products : workshop summary. _dWashington, District of Columbia : The National Academies Press, c2014 _hxvi, 134 pages _z9780309310000
797	2		_aebrary.
856	4	0	_uhttp://site.ebrary.com/lib/kliuc/Doc?id=11003355 _zAn electronic book accessible through the World Wide Web; click to view
942			_2lcc _cEBK
999			_c238766 _d238766